Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Safety and Efficacy of Disease Modifying Therapies After Switching from Natalizumab: A MENACTRIMS Observational Study
  1. Home
  2. Publications
  3. Safety and Efficacy of Disease Modifying Therapies After Switching from Natalizumab: A MENACTRIMS Observational Study

Safety and Efficacy of Disease Modifying Therapies After Switching from Natalizumab: A MENACTRIMS Observational Study

Authors:
  • MZMaya Zeineddine
    Maya Zeineddine
  • RARaed Al-Roughani
    Raed Al-Roughani
  • SKSamia Khoury
    Samia Khoury
  • AAAbdullah Al-Asmi
    Abdullah Al-Asmi
  • ACAmina Chentouf
    Amina Chentouf
  • JIJihad Inshasi
    Jihad Inshasi
  • RGRiadh Gouider
    Riadh Gouider
  • SMSaloua Mrabet
    Saloua Mrabet
  • NSNevin Shalaby
    Nevin Shalaby

Publisher website
Google Scholar
  • 18 December 2023
    • journal article
    • abstracts
    • Published by Elsevier in Multiple Sclerosis and Related Disorders
    • Vol. 80, 105299
    • DOI:10.1016/j.msard.2023.105299
Abstract
No abstract available
Keywords
  • NATALIZUMAB
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.